An in vitro study of theaflavins extracted from black tea to neutralize bovine rotavirus and bovine coronavirus infections

Veterinary Microbiology

Volumn 63, Issue 2-4, 1998, Pages 147-157

  Clark, K J ^a   Grant, P G ^a   Sarr, A B ^a   Belakere, J R ^a   Swaggerty, C L ^a   Phillips, T D ^a   Woode, G N ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Coronavirus; Neutralization; Rotavirus; Tea; Theaflavin; Theaflavin gallate

Indexed keywords

ANTIVIRUS AGENT; QUERCETIN; THEAFLAVIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CATTLE; CONTROLLED STUDY; CORONAVIRUS; DOSE RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; ROTAVIRUS; TEA; VIRUS INFECTION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIVIRAL AGENTS; BIFLAVONOIDS; CATECHIN; CATTLE; CATTLE DISEASES; CELL LINE; CHELATING AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONAVIRUS INFECTIONS; CORONAVIRUS, BOVINE; GALLIC ACID; MODELS, MOLECULAR; MOLECULAR CONFORMATION; ROTAVIRUS; ROTAVIRUS INFECTIONS; TEA;

EID: 0031787413     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(98)00242-9     Document Type: Article

References (22)

1. Anonymous, 1993. ChemPlus: Extension for HyperChem. Hypercube, Ont., Canada, pp. 95-127.
2. Anonymous, 1994. HyperChem: Computational Chemistry. Hypercube, Ont., Canada, pp. 1-285.
3. Clark, K.J., Sarr, A.B., Grant, P.G., Phillips, T.D., Woode, G.N., 1998. In vitro studies on the use of clay, clay minerals, and charcoal to adsorb bovine rotavirus and bovine coronavirus. Vet. Microbiol., 63, 137-146.
4. de Leeuw P.W., Ellens D.J., Talmon F.P., Zimmer G.N., Kommerij R. Rotavirus infections in calves: Efficacy of oral vaccination in endemically infected herds. Res. Vet. Sci. 29:1980;142-147.
5. Fernelius A.L., Ritchie A.E., Classick L.G., Norman J.O., Mebus C.A. Cell culture adaptation and propagation of a reovirus-like agent of calf diarrhea from a field outbreak in Nebraska. Arch. Virusforsch. 37:1972;114-130.
6. Green R.H. Inhibition of multiplication of influenza virus by extracts of tea. Proc. Soc. Exp. Biol. Med. 71:1949;84-85.
7. Hara Y., Matsuzaki T., Suzuki T. Angiotensin I converting enzyme inhibiting activity of tea component. Nippon Nokeikagaku kaishi. 61:1987;803-808.
8. Hussain K.A., Storz J., Kousoulas K.G. Comparison of bovine coronavirus (BCV) antigens: Monoclonal antibodies to the spike glycoprotein distinguish between vaccine and wild-type strains. Virology. 183:1991;442-445.
9. Mebus C.A., Stair E.L., Rhodes M.B., Twiehaus M.J. Neonatal calf diarrhea: Propagation, attentuation, and characteristics of a coronavirus-like agent. Am. J. Vet. Res. 34:1973;145-150.
10. Mukoyama A., Ushijima H., Nishimura S., Koike H., Toda M., Hara Y., Shimamura T. Inhibition of rotavirus and enterovirus infections by tea extracts. Jpn. J. Med. Sci. Biol. 44:1991;181-186.
11. Myers L.L., Snodgrass D.R. Colostral and milk antibody titers in cows vaccinated with a modified live rotavirus-coronavirus vaccine. J. Am. Vet. Med. Assoc. 181:1982;486-488.
12. Nakayama M., Toda M., Okubo S., Shimamura T. Inhibition of influenza virus infection by tea. Lett. Appl. Microbiol. 11:1990;38-40.
13. Nakayama M., Suzuki K., Toda M., Okubo S., Hara Y., Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral. Res. 21:1993;289-299.
14. Reed I.J., Muench H. A simple method in estimating fifty percent endpoints. Am. J. Hyg. 27:1938;493-497.
15. Roberts, E.A.H., Myers, M., 1959. The phenolic substances of manufactured tea. VI. The preparation of theaflavin and of theaflavin gallate. J. Sci. Food Agric., 176-179.
16. Sharpee R.L., Mebus C.A., Bass E.P. Characterization of a calf diarrheal coronavirus. Am. J. Vet. Res. 37:1976;1031-1041.
17. Snodgrass D.R., Nagy L.K., Sherwood D., Campbell I. Passive immunity in calf diarrhea: Vaccination with K99 antigen of enterotoxigenic Escherichia coli and rotavirus. Infect. Immun. 37:1982;586-591.
18. Storz J., Herrler G., Snodgrass D.R., Hussain K.A., Zhang X.M., Clark M.A., Rott R. Monoclonal antibodies differentiate between the haemagglutinating and the receptor-destroying activities of bovine coronavirus. J. Gen. Virol. 72:1991;2817-2820.
19. Takino Y., Ferretti A., Flanagan V., Gianturco M., Vogel M. The structure of theaflavin, a polyphenol of black tea. Tetrahedron Lett. 45:1965;4019-4025.
20. Waltner-Toews, D., Martin, S.W., Meek, A.H., McMillan, I., 1985. Crouch C.F. A field trial to evaluate the efficacy of a combined rotavirus-coronavirus/Escherichia coli vaccine in dairy cattle. Can. J. Comp. Med. 49, 1-9.
21. Woode G.N., Zheng S.L., Rosen B.I., Knight N., Gourley N.E., Ramig R.F. Protection between different serotypes of bovine rotavirus in gnotobiotic calves: Specificity of serum antibody and coproantibody responses. J. Clin. Microbiol. 25:1987;1052-1058.
22. Zheng S.L., Woode G.N., Melendy D.R., Ramig R.F. Comparative studies of the antigenic polypeptide species VP4, VP6, and VP7 of three strains of bovine rotavirus. J. Clin. Microbiol. 27:1989;1939-1945.